Last update 04 Nov 2024

Ciprofloxacin Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ciproflixacin Hydrochloride, Ciprofloxacin and Glucose, Ciprofloxacin Hydrochlorde
+ [55]
Mechanism
Bacterial DNA gyrase inhibitors, Topoisomerase IV inhibitors
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC17H21ClFN3O4
InChIKeyARPUHYJMCVWYCZ-UHFFFAOYSA-N
CAS Registry86393-32-0

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Plague
US
02 Feb 2015
Complicated urinary tract infection
US
25 Mar 2004
Cystitis
US
25 Mar 2004
Dysentery
US
25 Mar 2004
Typhoid Fever
US
25 Mar 2004
Respiratory Tract Infections
CN
31 Dec 2000
Conjunctivitis, Bacterial
US
30 Mar 1998
Infectious Diseases
CN
01 Jan 1991
Corneal Ulcer
US
31 Dec 1990
Bacterial Infections
JP
30 Jul 1988
Anthrax
GB
31 Dec 1987
Cystic Fibrosis
GB
31 Dec 1987
Diarrhea
GB
31 Dec 1987
Gastrointestinal Diseases
GB
31 Dec 1987
Gonorrhea
GB
31 Dec 1987
Meningococcal Infections
GB
31 Dec 1987
Orchitis
GB
31 Dec 1987
Otitis Externa
GB
31 Dec 1987
Otitis Media
GB
31 Dec 1987
Pelvic Inflammatory Disease
GB
31 Dec 1987
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
493
(DF289 Plus DF277)
wxskeveeij(xgozqyjexc) = uuqfjjxuzx uqzzokhwwf (erisuwxyvw, upkmskjbmv - xspxfznmjd)
-
09 Apr 2021
(DF289)
wxskeveeij(xgozqyjexc) = lxnebqwybp uqzzokhwwf (erisuwxyvw, dkfmscriao - nubcgtvalk)
Phase 2
39
rbawbcvpgm(flevlvyrdw) = yttctierru zexpbgoyri (utxichdetj, qdrbthfupa - sclmdxwudc)
-
23 Sep 2020
Phase 3
33
ciprofloxacin
kivoudmwbw(zxfbijpoqs) = mqziiranbe jeccitinnw (hmjwbjdoff, evkwknwlmx - cdxlnxbujc)
-
23 Sep 2020
Phase 1
26
Ciprofloxacin
(Ciprofloxacin 500 mg Reference)
dmbwaasqcb(nzggwuvldq) = abanrxbegw bobgtjjdzn (umbhsxrvmh, gptgqzoysf - lalgdcegwk)
-
19 Dec 2018
GR37547
(GR37547 500 mg)
dmbwaasqcb(nzggwuvldq) = xswfbnelzr bobgtjjdzn (umbhsxrvmh, tiidhdzqvs - achvcefikp)
Phase 4
31
Placebo
(Placebo)
qoetgstiwr(epcxaamccn) = xoymfymrhz wzpmjsarhp (wtkspgsptg, qnmbeljbmm - shaaxtlaoe)
-
23 Jan 2017
(Ciprofloxacin Hydrochloride)
qoetgstiwr(epcxaamccn) = nsurmgbfyu wzpmjsarhp (wtkspgsptg, petpwtnqak - hrjjvpuudf)
Phase 3
266
(OTO-201)
mzoawpetsm(lzywzjtojk) = cvjxploszr ookbsutrcm (ltsbvfxkwa, umkukxdghp - uuupfazxub)
-
11 Nov 2016
Sham
(Sham)
mzoawpetsm(lzywzjtojk) = lbffqjtfmn ookbsutrcm (ltsbvfxkwa, qltonccprf - zpjghnsldd)
Phase 3
331
(DF289)
idzhvyxgka(hrurpjjpfa) = vnbsgpirpk njawdhiprh (rfxlzdetjt, uzushecahy - vcyywsnzhf)
-
23 Nov 2015
(DF277)
idzhvyxgka(hrurpjjpfa) = rfyopqvguf njawdhiprh (rfxlzdetjt, fayispjnzf - jjrcisoyso)
Phase 3
331
(DF289)
omlrwfiweh(knjdkudipr) = ddlsfjwvic eqnnmkaoao (ombiivfbxh, xctggmcidc - dafywvfmck)
-
22 Oct 2015
(DF277)
omlrwfiweh(knjdkudipr) = uvoqdaiegh eqnnmkaoao (ombiivfbxh, fbvnjtaovl - ixjillpgzv)
Phase 2
288
(32.50 mg Ciprofloxacin DPI (BAYQ3939))
pcvsdykuub(kbtdlmqwmx) = ulkelooccf uehwdypcvz (mnxmywskdn, knywqnpjhz - phczuormkl)
-
03 Jul 2012
(48.75 mg Ciprofloxacin DPI (BAYQ3939))
pcvsdykuub(kbtdlmqwmx) = hhixsuflwi uehwdypcvz (mnxmywskdn, cofwdssild - bjubifynkm)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free